Tetrahydrofuran
Medchemexpress LLC Benzobicyclon | 156963-66-5 | MFCD09751259 | 98.0% | 446.97 | C22H19ClO4S2 | 10 MG
Benzobicyclon analytical standard is supplied for research and analytical applications as a reference material. It is a 4-HPPD inhibitor herbicide that hydrolyzes in water to form the active herbicidal species, producing bleaching and death in susceptible plants. The material is provided at high purity for accurate analytical and testing use.
- Intended for research and analytical applications.
- High purity suitable for reference and analytical workflows.
- Hydrolyzes in water to form the active herbicide.
- Effective against grass, sedge, and broadleaf weeds.
- Suitable for analytical quantification and method development.
Glen Research Tetrahydrofuran/Pyridine/Acetic Anhydride, 2000 mL, 0.2 micron filtered, Hazardous material: Yes
This Glen Research product is a high-purity blend of Tetrahydrofuran, Pyridine, and Acetic Anhydride supplied in a 2000 mL volume. It is prepared to exacting specifications for optimal performance in demanding scientific applications, particularly oligonucleotide synthesis. Processed through a 0.2 micron filter during packaging to minimize particulate contamination, this reagent is ideal for ensuring high synthesis efficiency.
- 2000 mL volume
- Primary components include Tetrahydrofuran, Pyridine, and Acetic Anhydride
- Application in oligonucleotide synthesis
- Processed through a 0.2 micron filter
- Prepared to exacting specifications
- Hazardous material
- Stored at controlled room temperature
Medchemexpress LLC Ralaniten triacetate | 1637573-04-6 | 98.8% | 521.00 g/mol | C27H33ClO8 | 10MG
Ralaniten triacetate is an orally active prodrug that targets the androgen receptor N-terminal domain (AR-NTD) and is provided for non-clinical research into AR-driven prostate cancer mechanisms. Manufacturer data include analytical and handling information to support experimental use.
- Prodrug of ralaniten that targets the androgen receptor N-terminal domain.
- Orally active in preclinical studies.
- High purity suitable for research applications.
- Molecular weight 521.00 g/mol; formula C27H33ClO8.
- Appearance: liquid, colorless to light yellow.
- Storage conditions provided for pure form and for solutions.
- For research use only; not for human or veterinary use.
![eMolecules AOBChem USA / (24-Dichlorophenyl)trimethylsilane / 250mg / 768965367 / 66675 / / 149021-04-5 / [null] / 219.180 / C9H12Cl2Si](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502464162.JPG-250.jpg)
eMolecules AOBChem USA / (24-Dichlorophenyl)trimethylsilane / 250mg / 768965367 / 66675 / / 149021-04-5 / [null] / 219.180 / C9H12Cl2Si
AOBChem USA / (24-Dichlorophenyl)trimethylsilane / 250mg / 768965367 / 66675 / / 149021-04-5 / [null] / 219.180 / C9H12Cl2Si
Medchemexpress LLC GSK3182571 | 2135595-04-7 | 99.8% | 495.02 g/mol | C25H31ClN8O | 50MG
GSK3182571 is a non-selective, broad-spectrum pan-kinase inhibitor provided as a solid powder for research use. It is intended for in vitro and cell-based studies to probe kinase networks and off-target effects; not for human use.
- High purity (99.75%).
- Molecular weight 495.02 g/mol.
- Molecular formula C25H31ClN8O.
- Soluble in DMSO at 100 mg/mL (202.01 mM) with ultrasonic aid and pH adjustment.
- Recommended storage: powder -20°C (up to 3 years) or 4°C (up to 2 years).
- White to light yellow solid appearance.